Tci Wealth Advisors, Inc. In Med Pharmaceuticals Inc. Transaction History
Tci Wealth Advisors, Inc.
- $1.01 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding INM
# of Institutions
15Shares Held
440KCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ307KShares$70,6645.39% of portfolio
-
Virtu Financial LLC New York, NY86.7KShares$19,9370.0% of portfolio
-
Xtx Topco LTD London, X017.8KShares$4,0980.0% of portfolio
-
Hrt Financial LP New York, NY16KShares$3,6790.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.1KShares$2,7820.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $209K
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...